This study provides new evidence that DHA eradicates CSC characteristics and tumor neovascularization by regulating the miR-200b–BMI-1/VEGF-A/VEGFR2 axis, thereby improving outcomes in patients with platinum-resistant relapse, a major obstacle in the clinical management of OC. Here, BMI1 is linked to neoplasm.